Astrana Health ASTH Noncontrolling interests in subsidiaries
Noncontrolling interests in subsidiaries at other companies
Other financials
Where this comes from
Reported directly by Astrana Health in its filing.
Tagged under the XBRL concept us-gaap:MinorityInterest.
The official record: Astrana Health’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Astrana Health's noncontrolling interests in subsidiaries.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Astrana Health's noncontrolling interests in subsidiaries?
- Astrana Health (ASTH) reported noncontrolling interests in subsidiaries of $14.93M in Q1 2026.
- How has Astrana Health's noncontrolling interests in subsidiaries changed year-over-year?
- Astrana Health's noncontrolling interests in subsidiaries increased by 194.4% year-over-year, from $5.07M to $14.93M.
- What is the long-term trend for Astrana Health's noncontrolling interests in subsidiaries?
- Over 5 years (2020 to 2025), Astrana Health's noncontrolling interests in subsidiaries has grown at a 176.3% compound annual growth rate (CAGR), from $87K to $14.01M.
- What does noncontrolling interests in subsidiaries mean?
- This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.